Leveraging Analytical Quality by Design Principles for Efficient Development of a Targeted Assay Method for Routine Monitoring of Mannose-5 Glycans Using Fluorescence Detection

Significance of the Topic

Monitoring specific glycan structures such as mannose-5 (Man-5) on monoclonal antibodies is critical to ensure consistent pharmacokinetics and efficacy in biopharmaceutical production. Analytical Quality by Design (AQbD) offers a systematic, risk-based approach to optimize chromatographic assays, improving robustness, efficiency, and regulatory compliance compared to traditional one-factor-at-a-time methods.

Objectives and Study Overview

The primary goal was to transform a broad N-glycan HILIC platform into a targeted fluorescence-based assay for routine Man-5 quantitation. By applying AQbD principles, design of experiments (DoE) and multivariate statistical tools established a Method Operable Design Region (MODR) that balances resolution, run time, and method robustness.

Methodology and Instrumentation

Sample preparation involved spiking RapiFluor-MS labeled high-mannose standards into intact monoclonal antibody matrix. Critical method parameters (CMPs) screened included buffer concentration, column temperature, and gradient slope using Fusion QbD® software with Empower™ 3 CDS for seamless DoE execution.

• Liquid chromatography: ACQUITY™ Premier System with BEH Amide Column (2.1×150 mm, 1.7 µm)
• Detection: ACQUITY FLR Detector (λ_exc=265 nm, λ_em=425 nm)
• Mass confirmation: ACQUITY QDa™ II Mass Detector (ESI+, 350–1 500 m/z)
• Software: Empower 3.8.1 and Fusion QbD® 9.9.2

Key Results and Discussion

Initial DoE identified that lower column temperature (30 °C) and shallow gradient maximized resolution between Man-5 and coeluting species FA1G1/A2G1. A second DoE optimized gradient endpoints and run time, enabling method run times under 25 minutes while maintaining USP half-height resolution ≥2.0. Robustness simulations guided selection of a MODR with Cpk ≥1.33, ensuring reliable performance under normal operating variability. Experimental verification at five runs confirmed predicted resolution and precision.

Benefits and Practical Applications

• High specificity and resolution for Man-5 quantitation using FLR detection
• Reduced analysis time and improved sensitivity compared to generic glycan assays
• Regulatory confidence through a risk-based MODR aligned with ICH Q14 guidance

Future Trends and Opportunities

Further advances may include integration of higher-throughput columns, automated sample handling, and extension to other critical glycan species. Machine-learning enhanced DoE tools could further accelerate method optimization and ensure continuous quality improvement in biopharmaceutical analytics.

Conclusion

Applying AQbD to a universal N-glycan HILIC method yielded a robust, targeted fluorescence assay for routine monitoring of Man-5 glycans. The data-driven DoE approach established a validated MODR, delivering high resolution, reduced variability, and compliance readiness for biopharmaceutical quality control.

References

1. Yu YQ. Released N-linked Glycan Analysis Using the Glycan Application Solution with UNIFI. Waters Application Note. January 2016.
2. ICH Q14 Guideline on Analytical Procedure Development. ICH. November 2023.
3. Goetze AM et al. High-mannose Glycans on the Fc Region of Therapeutic IgG Antibodies Increase Serum Clearance in Humans. Glycobiology 21(7):949–959, 2011.